AMGN: AMGEN INC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 16 hrs, 41 mins

Symbol	Value	Change	Percentage Change
DJIA	11,430.21	12.78	0.11%
NASDAQ	2,380.38	-8.70	-0.36%
S&P 500	1,277.72	3.18	0.25%

AMGEN INC

AMGN

Stock price

63.81 0.24 0.38%

as of 04:00 PM EDT on 08/21/2008 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

63.8587 0.0487 0.08%

as of 04:27 PM EDT on 08/21/08

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: AMGN

AMGEN INC Profile

Amgen is among the biggest of the biotech big'uns. And it's determined to get even bigger. The company uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, and metabolic diseases. Anti-anemia drugs Epogen and Aranesp account for more than one-third of its sales. Enbrel, another leading drug, treats rheumatoid arthritis and is one of the best-selling drugs in this multi-billion-dollar market. The company has a promising drug pipeline and marketing alliances with Hoffmann-La Roche, Japanese brewer and drugmaker Kirin, and other pharmas. Amgen sells its products primarily through wholesale distributors in North America and Europe.

Kevin W. Sharer: CEO

1 Amgen Center Dr.

Thousand Oaks, CA 91320-1799

http://www.amgen.com

Phone: 805-447-1000

Fax: 805-447-1010

Sector: Healthcare Industry: Drugs

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$14,771,000,000	3.5%	$3,166,000,000	17,500

Key Executives: AMGN

Name	Title	Officer Since
Kevin W. Sharer	CEO	11/1/92
Robert A. Bradway	CFO	-
Thomas J. Flanagan	Chief Information Officer	-
Michael A. Kelly	Chief Accounting Officer	-
David J. Scott	General Counsel	-
Madhu Balachandran	Senior VP, Divisional	-
Frank J. Biondi, Jr.	Director	1/1/02
Frederick W. Gluck	Director	2/1/98

View All Key Executives

Mr. David J. Scott, age 55, became Senior Vice President, General Counsel and Secretary in March 2004. From May 1999 to February 2004, Mr. Scott served as Senior Vice President and General Counsel of Medtronic, Inc. and also as Secretary from January 2000. From December 1997 to April 1999, Mr. Scott served as General Counsel of London-based United Distillers & Vintners. Mr. Scott also served in executive roles at Grand Metropolitan plc and RJR... View Full Profile

David J. Scott

Mr. Thomas J. Flanagan, age 58, became Senior Vice President and Chief Information Officer in October 2006. From June 2004 to October 2006, Mr. Flanagan served as Vice President, Information Systems. From December 1995 to May 2004, Mr. Flanagan served in a variety of executive positions including Chief Information Officer and Vice President, Global Service Delivery at MCI.... View Full Profile

Thomas J. Flanagan

Mr. Robert A. Bradway, age 45, became Executive Vice President and Chief Financial Officer in April 2007. He joined the Company in 2006 as Vice President, Operations Strategy. Previously, Mr. Bradway had an 18 year career at Morgan Stanley in New York and London where he was a managing director in investment banking. Mr. Bradway led Morgan Stanley's healthcare practice in Europe for several years and also ran Morgan Stanley's European banking... View Full Profile

Robert A. Bradway

Succeeding Bonanni as senior vice president, Manufacturing will be Madhu Balachandran, who was previously vice president, operations at Amgen Manufacturing, Ltd. in Juncos, Puerto Rico.... View Full Profile

Madhu Balachandran

Mr. Frank J. Biondi, Jr., age 63, has served as a director of the Company since January 2002. Since March 1999, he has served as Senior Managing Director of WaterView Advisors LLC, an investment advisor organization. From April 1996 to November 1998, Mr. Biondi served as Chairman and Chief Executive Officer of Universal Studios, Inc. From July 1987 to January 1996, Mr. Biondi served as President and Chief Executive Officer of Viacom, Inc. Mr.... View Full Profile

Frank J. Biondi, Jr.

Mr. Frederick W. Gluck, age 72, has served as a director of the Company since February 1998. He is currently the Chairman of the Board and Chief Executive Officer of CytomX, LLC, a developer of cell sorting products. Mr. Gluck is a former managing partner of McKinsey & Company, Inc., an international management consulting firm. From 1967 to 1995, he served with McKinsey and from 1988 to 1994 he led the firm as its Managing Director, when he... View Full Profile

Frederick W. Gluck

Admiral J. Paul Reason, USN (Retired), age 67, has served as a director of the Company since January 2001. From September 2005 to September 2006, he served as Vice Chairman and Director of Metro Machine Corporation, a privately-held ship repair company. From July 2000 to September 2005, he served as President and Chief Operating Officer of Metro Machine. From December 1996 to September 1999, Adm. Reason was a U.S. Navy Four Star Admiral and... View Full Profile

Admiral J. Paul Reason, USN

Mr. Brian McNamee, age 51, became Senior Vice President, Human Resources in June 2001. From November 1999 to June 2001, Mr. McNamee served as Vice President of Human Resources at Dell Computer Corp. From 1998 to 1999, Mr. McNamee served as Senior Vice President, Human Resources for the National Broadcasting Corporation, a division of GE. From July 1988 to November 1999, Mr. McNamee held human resource positions at GE.... View Full Profile

Brian McNamee

Dr. David Baltimore, age 70, has served as a director of the Company since June 1999. He is currently President Emeritus of and Robert Andrews Millikan Professor of Biology at the California Institute of Technology, or Caltech. From October 1997 to September 2006, Dr. Baltimore was the President of Caltech. From July 1995 to October 1997, Dr. Baltimore was an Institute Professor at the Massachusetts Institute of Technology, or MIT, and from July... View Full Profile

Dr. David Baltimore

Dr. David Baltimore, age 70, has served as a director of the Company since June 1999. He is currently President Emeritus of and Robert Andrews Millikan Professor of Biology at the California Institute of Technology, or Caltech. From October 1997 to September 2006, Dr. Baltimore was the President of Caltech. From July 1995 to October 1997, Dr. Baltimore was an Institute Professor at the Massachusetts Institute of Technology, or MIT, and from July... View Full Profile

Dennis M. Fenton

Dr. Fabrizio Bonanni, age 61, became Executive Vice President, Operations in August 2007. He has served as Senior Vice President, Manufacturing of the Company since 2004. Dr. Bonanni joined the Company in 1999 as Senior Vice President, Quality and Compliance and in June 2001 he also became the Corporate Compliance Officer. Previously, Dr. Bonanni held various management positions at Baxter International, Inc. from 1974 to 1999, including... View Full Profile

Fabrizio Bonanni

Mr. George J. Morrow, age 55, became Executive Vice President of Worldwide Sales and Marketing in January 2001 and became Executive Vice President, Global Commercial Operations in April 2003. From January 1999 to December 2000, Mr. Morrow was President and Chief Executive Officer of Glaxo Wellcome Inc. ("Glaxo"), a subsidiary of GlaxoSmithKline. From January 1997 to December 1998, Mr. Morrow was Managing Director of Glaxo Wellcome U.K., also a... View Full Profile

George J. Morrow

Dr. Gilbert S. Omenn, age 66, has served as a director of the Company since January 1987. Since September 1997, he has been Professor of Internal Medicine, Human Genetics and Public Health at the University of Michigan. From September 1997 to July 2002, Dr. Omenn also served as Executive Vice President for Medical Affairs and as Chief Executive Officer of the University of Michigan Health System. From July 1982 to September 1997, Dr. Omenn was... View Full Profile

Dr. Gilbert S. Omenn

Ms. Judith C. Pelham, age 62, has served as a director of the Company since May 1995. She is currently President Emeritus of Trinity Health, a national system of healthcare facilities, including hospitals, long-term care, home care, psychiatric care, residences for the elderly and ambulatory care, and the third largest Catholic healthcare system in the U.S. and sits on the board of trustees of Smith College. From May 2000 to December 2004, Ms.... View Full Profile

Judith C. Pelham

Mr. Kevin W. Sharer, age 60, has served as a director of the Company since November 1992. Since May 2000, Mr. Sharer has been Chief Executive Officer and President of the Company and has also been Chairman of the Board since December 2000. From October 1992 to May 2000, Mr. Sharer served as our President and Chief Operating Officer. From April 1989 to October 1992, Mr. Sharer was President of the Business Markets Division of MCI Communications... View Full Profile

Kevin W. Sharer

Mr. Kevin W. Sharer, age 60, has served as a director of the Company since November 1992. Since May 2000, Mr. Sharer has been Chief Executive Officer and President of the Company and has also been Chairman of the Board since December 2000. From October 1992 to May 2000, Mr. Sharer served as our President and Chief Operating Officer. From April 1989 to October 1992, Mr. Sharer was President of the Business Markets Division of MCI Communications... View Full Profile

Richard D. Nanula

Dr. Roger M. Perlmutter, age 55, became Executive Vice President of Research and Development in January 2001. From July 1999 to December 2000, Dr. Perlmutter was Executive Vice President, Worldwide Basic Research and Preclinical Development of Merck Research Laboratories. From February 1999 to July 1999, Dr. Perlmutter served as Executive Vice President of Merck Research Laboratories, and from February 1997 to January 1999, as Senior Vice... View Full Profile

Roger Perlmutter, M.D.

Mr. Kelly, age 48, has been the Company's Vice President, Finance for Process Development, Operations and Quality since February 10, 2003. From 2000 to 2002, Mr. Kelly was Vice President, Finance and Chief Financial Officer at Tanox, Inc., a biotechnology company. From 1998 to 2000, Mr. Kelly was Corporate Controller at Biogen, Inc., a biotechnology company. From 1981 to 1998, Mr. Kelly progressed through positions of increasing responsibility in... View Full Profile

Michael A. Kelly

Mr. Jerry D. Choate, age 69, has served as a director of the Company since August 1998. From January 1995 to January 1999, Mr. Choate served as Chairman of the Board and Chief Executive Officer of The Allstate Corporation, an insurance holding company. From August 1994 to January 1995, Mr. Choate served as President and Chief Executive Officer of Allstate and had previously held various management positions at Allstate since 1962. Mr. Choate is a... View Full Profile

Jerry D. Choate

Mr. Leonard D. Schaeffer, age 62, has served as a director of the Company since March 2004. He is currently Chairman of the Board of Surgical Care Affiliates, LLC and a Senior Advisor for Texas Pacific Group, a private investment firm. Mr. Schaeffer is the former Chairman of the Board of Directors of WellPoint Inc., the largest health insurance company in the United States. From 1992 through 2004, he was Chairman and Chief Executive Officer of... View Full Profile

Leonard D. Schaeffer

Mr. Frank C. Herringer, age 65, has served as a director of the Company since May 2004. Mr. Herringer has been Chairman of the Board of Transamerica Corporation, a financial services company, since 1995. From 1991 to 1999, he served as Chief Executive Officer of Transamerica and from 1986 to 1999 he served as President. From 1999 to 2000, Mr. Herringer served on the Executive Board of Aegon N.V. and as Chairman of the Board of Aegon U.S.A. Mr.... View Full Profile

Frank C. Herringer

Dr. Vance D. Coffman, 63, has served as a director of the Company since October 2007. Dr. Coffman was elected at the recommendation of Mr. Frank C. Herringer in his capacity as Chairman of the Governance and Nominating Committee. Dr. Coffman served in various executive capacities at Lockheed Martin Corporation, a high technology aerospace and defense company. He served as Vice Chairman of the Board and Chief Executive Officer from 1997, as... View Full Profile

Dr. Vance D. Coffman

Top Competitors: AMGN

View Detailed Competitors Chart

Insider Trends: AMGN
Sentiment for AMGN is POSITIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: AMGN

Date	Name	Shares	Transaction Type	Market Value
06/03/08	CHOATE JERRY D	24,080	Sale	$1.06 M
06/03/08	CHOATE JERRY D	60,000	Exercise of Stock Options	$1.06 M
05/27/08	KELLY MICHAEL A	5,000	Planned Sale	$215,000.00

View All Insider Activity

Ownership Breakdown : AMGN

Large Block Holder Type	Number
Institutions	1,298.00
Mutual Fund	2,625.00
Other Major	22.00

Full Details

Indices : AMGN

Symbol	Name	Last Trade	Change
$RUI.X	Russell 1000 Index	698.96	1.70 0.24%
$INX	S&P 500 Index	1,277.72	3.18 0.25%
$OEX	S&P 100 Index	588.89	1.24 0.21%
—	Fortune 500 Industrial Index	—	——%

View all Indices that include AMGN

Short Interest Volume: AMGN

Data as of 7/28/08

Current Short Interest Shares	31.66 M
Current Short Interest Ratio	2.20
Float	1.06 B

Short Interest as % of Float	3.00
Average Daily Volume	13.20 M
Outstanding Shares	1.06 B

Full Details

SEC Filings: AMGN

Accepted Date	Description
08/18/2008	SEC Filing: Current Event
08/08/2008	SEC Filing: Quarterly Financials
08/01/2008	SEC Filing: Insider Buy/Sell

View all SEC Filings

Get Quote Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

AMGEN INC

AMGN

Stock price

63.81 0.24 0.38%

as of 04:00 PM EDT on 08/21/2008 in USD (NASDAQ Delay: 15 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: AMGN

Quote Search Search the Web Search

Live Updates:

Ticker

Dynamic view of the market

AMGEN INC

AMGN

Stock price

Extended Hours

Analyst Consensus

AMGEN INC Profile

Key Executives: AMGN

Top Competitors: AMGN

Insider Trends: AMGN

Insider Transactions: AMGN

Ownership Breakdown : AMGN

Indices : AMGN

Short Interest Volume: AMGN

SEC Filings: AMGN

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials